American Journal of Respiratory and Critical Care Medicine (AJRCCM)
Published October 30, 2026
00:00
--:--
Dupilumab is associated with improved lung functions in patients with COPD and type 2 inflammatio...
November 2, 2026
Share
Dupilumab is associated with improved lung functions in patients with COPD and type 2 inflammation: a post hoc analysis of the BOREAS and NOTUS trials.
